Thumbay University Hospital Launches Institute of Neurosciences

IMT News Desk
IMT News Desk
· 2 min read
Thumbay University Hospital launches its Institute of Neurosciences for advanced brain, spine and nerve care with multidisciplinary expertise.

Thumbay University Hospital has inaugurated the Thumbay Institute of Neurosciences, a dedicated center for the diagnosis, treatment, and management of complex disorders of the brain, spine, and nervous system. The launch marks a major step in specialized healthcare within the Thumbay Group ecosystem and strengthens the hospital’s position as one of the region’s leading academic medical centers.

“Neurological disorders require precision, speed and multidisciplinary expertise. With this institute, we are bringing together all of that under one roof, supported by technology, skilled specialists and a patient-first approach,” said Akbar Moideen Thumbay, Vice President, Healthcare Division, Thumbay Group.

The Thumbay Institute of Neurosciences is built around a multidisciplinary team of neurosurgeons, neurologists, interventional radiologists, neuro-technicians, and rehabilitation specialists. Neurology services cover stroke, epilepsy, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, migraines, neuropathy, vertigo, and sleep disorders, supported by advanced diagnostics such as EEG, EMG, nerve conduction studies, and neuro-imaging.

On the surgical side, the institute handles complex brain, spine, and nerve conditions using microsurgical and minimally invasive techniques. These include brain tumors, vascular abnormalities, traumatic brain injuries, spinal disorders, and pediatric neurological conditions. Procedures such as cranioplasty, hydrocephalus management, and advanced spinal fixation are performed with precision using neuronavigation technology and intraoperative neuromonitoring.

What sets the institute apart is its integration of advanced neuro-rehabilitation with technology-driven therapies. Patients have access to robotic rehabilitation, Transcranial Magnetic Stimulation (TMS), Hyperbaric Oxygen Therapy, gait and motion analysis, EMG-based functional assessments, and Ekso Bionics exoskeleton-assisted rehabilitation. The objective is to restore mobility, independence, and quality of life.

The institute follows a structured care pathway in which neurologists manage non-surgical conditions and neurosurgeons step in when intervention is required. This approach ensures that patients receive the right care at the right time, without unnecessary procedural complexity.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk